Cerebral Cavernous Malformation causes fragile, bleeding vascular lesions in the brain with no non-surgical treatment options. Researchers discovered that dabrafenib, an approved childhood cancer drug, suppresses vessel leakage and shrinks lesions in preclinical models.
Cerebral Cavernous Malformation causes fragile, bleeding vascular lesions in the brain with no non-surgical treatment options. Researchers discovered that dabrafenib, an approved childhood cancer drug, suppresses vessel leakage and shrinks lesions in preclinical models.
Share this Article
Recommended